| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(Circulation. 2003;108:452.)
© 2003 American Heart Association, Inc.
Clinical Investigation and Reports |
From the Minneapolis Heart Institute at Abbott Northwestern Hospital, Minneapolis, Minn.
Correspondence to Jay H. Traverse, MD, Minneapolis Cardiology Associates, Minneapolis Heart Institute, 920 East 28th Street, Suite 300, Minneapolis, MN 55407. E-mail trave004{at}tc.umn.edu
Received February 5, 2003; revision received April 24, 2003; accepted April 25, 2003.
| Abstract |
|---|
|
|
|---|
Methods and Results We studied 74 consecutive patients who received the Symmetry Bypass System aortic connector at the time of CABG. A total of 131 of 144 proximal vein graft anastomoses were performed with this device. The left internal mammary artery was used in 62 patients, and 61 patients had "off-pump" coronary revascularization. A total of 11 patients were readmitted with chest pain consistent with unstable angina 173±39 days after CABG. Five of the 11 patients had previous in-stent restenosis before CABG. At angiography, 20 saphenous vein bypass grafts containing 19 connectors were found to have severe stenosis (n=12) or occlusion (n=6) and were treated with angioplasty and stenting or medical therapy. Seven of 11 patients were readmitted 76±11 days later with recurrent chest pain and were found to have severe stenosis at the previously stented connector site. Six patients underwent angioplasty followed by brachytherapy. Three of these patients redeveloped chest pain and were readmitted 151±71 days later. Two patients were started on oral Rapamune, and one patient underwent redo-CABG.
Conclusion Eleven of 74 patients who received aortic connectors at the time of CABG developed symptomatically significant stenosis or occlusion at the connector site shortly after CABG, requiring multiple repeat interventions, including brachytherapy.
Key Words: bypass stents restenosis coronary disease
| Introduction |
|---|
|
|
|---|
However, off-pump bypass surgery still requires the use of aortic side-biting clamps to perform each proximal anastomosis, which may lead to aortic injury4 and the occurrence of stroke in this population. The use of recently developed sutureless aortic-saphenous vein graft connectors may facilitate off-pump coronary revascularization5 and reduce the incidence of stroke and cerebral microemboli in patients by eliminating the need for partial aortic clamping.6 In the present article, we report the clinical, angiographic, and interventional follow-up in the first 74 patients who received aortic connectors at our institution at the time of CABG.
| Methods |
|---|
|
|
|---|
There were 10 device failures at the time of implantation in 7 patients. This included 8 instances of excessive bleeding at the connector site and 2 instances of connector thrombosis. There were no perioperative strokes in the group.
| Results |
|---|
|
|
|---|
A total of 20 vein grafts with 19 connectors were studied at angiography (Table); 12 had severe stenosis at the connector site, and 6 were occluded. Eight patients underwent coronary angioplasty (PTCA) and stenting at the connector site and/or 5 patients underwent PTCA/stenting of their native coronary arteries. One patient underwent stenting at the left internal mammary artery anastomosis. Two patients were treated medically, and one of them was started on oral Rapamune (Wyeth-Ayerst) at a dose of 2 mg/d for 4 weeks. One patient had a small, non-Q-wave myocardial infarction after the procedure (creatine kinase-MB of 15 U; Figure 1)
|
|
Seven of the 11 patients were readmitted with their second episode of chest pain 76±11 days after their first interventional procedure after CABG (Table). After angiography, 6 patients underwent angioplasty at the connector site followed by brachytherapy (Checkmate, Cordis) with gamma irradiation (Ir-92) and received 18 Gy at 2 mm from the source at 8 connector sites. Two patients underwent PTCA and brachytherapy of their native coronary arteries, and one patient was started on oral Rapamune. One patient had a non-Q-wave myocardial infarction after the procedure (creatine kinase-MB of 102 U; Figure 2).
|
Three of the 11 patients were readmitted with their third episode of chest pain 131±70 days after their second interventional procedure. One patient underwent PTCA of a diagonal branch and was started on Rapamune. A second patient underwent PTCA and brachytherapy at the left internal mammary artery anastomosis. The third patient underwent repeat CABG.
One patient who was managed medically after his first admission for chest pain died from the development of line sepsis after peripheral vascular surgery.
| Discussion |
|---|
|
|
|---|
The successful long-term treatment of saphenous vein graft disease remains a significant challenge because of the recurrence of significant stenosis after percutaneous intervention or disease progression in other portions of the graft.7 Initial treatment of vein graft disease with stenting seems to result in initial lower rates of target vessel revascularization8 and major cardiac events9 compared with PTCA, although this benefit was not sustained at 3 years.10 The presence of aorto-ostial disease remains a subset of vein graft disease that is significantly problematic to treat, in part because of the high elastic recoil and external compression unique to that location.11 The use of stents in this location is still associated with significant target lesion revascularization at 1 year (approaching 20%) and may be associated with a significant incidence of periprocedural non-Q-wave myocardial infarction.12 In our cohort, we observed a 64% incidence of target lesion revascularization after stenting at the connector site, which is much higher than previously reported at the aorto-ostium in sutured vein grafts. These observations may suggest that the presence of a metallic foreign body at the aorto-ostium or the manipulation and attachment of the vein graft to the connector could result in endothelial injury13 and contribute to a more vigorous injury response after stenting.
The 8 connector sites in 6 patients that developed in-stent restenosis after stenting at the connector site were successfully treated with brachytherapy during their second interventional procedure. However, 4 of these sites in 3 patients redeveloped severe stenosis or occlusion leading to repeat bypass surgery in one patient and initiation of Rapamune in two patients. Previous studies in saphenous vein bypass grafts with in-stent restenosis have demonstrated a 70% reduction in target lesion revascularization with brachytherapy compared with repeat PTCA or stenting.14 The 57% repeat target vessel revascularization is higher than previously reported after brachytherapy in vein grafts, although the number of patients in our group was small and all sites were localized to the aorto-ostium.
We observed the development of symptomatic stenosis or occlusion at 18 connector sites in 11 patients at angiography during their initial on-average presentation of 6 months after CABG. This comprises an attrition rate of 13.7% of a total of 131 connectors placed at the time of surgery. It is possible that this represents a significant underestimation of the true incidence of stenosis or occlusion at the connector site because only symptomatic patients underwent angiography. Previous serial angiographic studies in patients after CABG have demonstrated a significant rate of vein graft attrition in the first month after surgery, with a rate of occlusion between 12% and 13% at 1 month, which increased to 19% to 21% at 1 year.15,16
There have been several preliminary reports describing proximal anastomotic connector systems such as the type used in this study, with angiographic follow-up available in a small group of patients. Wiklund et al17 presented the angiographic findings in the first 10 of 34 patients 4 to 6 months after CABG. There were a total of 10 proximal anastomoses performed with the connector and 14 performed with sutures. At angiographic follow-up, all the patients were asymptomatic, and there was a severe stenosis in one of the sutured vein grafts and one occlusion at the connector site. Calafiore et al18 presented their initial clinical experience in 17 patients who received the aortic anastomotic device (AAD) proximal anastomotic device (Bypass Ltd). Follow-up angiograms in 6 patients performed 48±26 days after CABG revealed that all the proximal anastomoses were widely patent.
There are important technical limitations with these devices that may predispose the vein grafts to develop kinking, which may lead to occlusion of the graft and contribute to the observations reported in this study. Because the connector must deploy the vein graft at a 90-degree takeoff angle from the aorta, the proximal portion of the graft may kink as it courses inferiorly toward the heart. A second technical consideration involves selecting the proper length of vein to graft because the device requires that the proximal anastomosis be performed first. A short segment of vein may be overly stretched when performing the distal anastomosis, whereas too long a segment may result in kinking of the graft.17
| Conclusions |
|---|
|
|
|---|
| Footnotes |
|---|
Presented in part at the 75th Scientific Sessions of the American Heart Association, Chicago, Ill, November 1720, 2002, and published in abstract form (Circulation. 2002;106(suppl II):II-638).
| References |
|---|
|
|
|---|
2. Ricci M, Karamanoukian HL, Abraham R, et al. Stroke in octogenarians undergoing coronary artery surgery with and without cardiopulmonary bypass. Ann Thorac Surg. 2000; 69: 14711475.
3. Arom KV, Flavin TF, Emery RW, et al. Safety and efficacy of off-pump coronary artery bypass grafting. Ann Thorac Surg. 2000; 69: 70410.
4. Eckstein FS, Bonilla LF, Englberger L, et al. The St Jude Medical symmetry aortic connector system for proximal vein graft anastomoses in coronary artery bypass grafting. J Thorac Cardiovasc Surg. 2002; 123: 777782.
5. Mack MJ, Dewey TM, Magee MJ. Facilitated anastomosis for reoperative circumflex coronary revascularization on the beating heart through a left thoracotomy. J Thorac Cardiovasc Surg. 2002; 123: 816817.
6. Watters MP, Cohen AM, Monk CR, et al. Reduced cerebral embolic signals in beating heart coronary surgery detected by transcranial Doppler ultrasound. Br J Anaesth. 2000; 84: 629631.
7. De Feyer PJ, Van Suylen RJ, De Jaegere PP, et al. Balloon angioplasty for the treatment of lesions in saphenous vein bypass grafts. J Am Coll Cardiol. 1993; 2: 15391549.
8. Brener SJ, Ellis SG, Apperson-Hansen C, et al. Comparison of stenting and balloon angioplasty for narrowings in aortocoronary saphenous vein conduits in place for more than five years. Am J Cardiol. 1997; 79: 1318.[CrossRef][Medline] [Order article via Infotrieve]
9. Savage MP, Douglas JS, Fischman DL. Stent placement compared with balloon angioplasty for obstructed coronary bypass grafts. N Engl J Med. 1997; 337: 740747.
10. Keely EC, Velez CA, ONeill WW, et al. Long-term clinical outcome and predictors of major adverse cardiac events after percutaneous interventions on saphenous vein grafts. J Am Coll Cardiol. 2001; 38: 659665.
11. Hong MK, Mehran R, Dangas G, et al. Are we making progress with percutaneous saphenous vein graft treatment? J Am Coll Cardiol. 2001; 38: 150154.
12. Bhargava B, Kornowski R, Mehran R, et al. Procedural results and intermediate clinical outcomes after multiple saphenous vein graft stenting. J Am Coll Cardiol. 2000; 35: 389397.
13. Tsui JC, Souza DS, Filbey D, et al. Preserved endothelial integrity and nitric oxide synthase in saphenous vein grafts harvested by a no-touch technique. Br J Surg. 2001; 88: 12091215.[CrossRef][Medline] [Order article via Infotrieve]
14. Waksman R, Ajani AE, White RL, et al. Intravascular gamma radiation for in-stent restenosis in saphenous-vein bypass grafts. N Engl J Med. 2002; 346: 11941199.
15. Fitzgibbon GM, Kafka HP, Leach AJ, et al. Coronary artery bypass fate and patient outcome: angiographic follow-up of 5065 grafts related to survival and reoperation in 1388 patients during 25 years. J Am Coll Cardiol. 1996; 28: 616626.[Abstract]
16. Bourassa MG, Enjalbert M, Campeau L, et al. Progression of atherosclerosis in coronary arteries and bypass grafts: ten years later. Am J Cardiol. 1984; 53: 102C107C.[CrossRef][Medline] [Order article via Infotrieve]
17. Wiklund L, Bugge M, Berglin E. Angiographic results after the use of a sutureless aortic connector for proximal vein graft anastomoses. Ann Thorac Surg. 2002; 73: 19931994.
18. Calafiore AM, Bar-El Y, Vitolla G, et al. Early clinical experience with a new sutureless anastomotic device for proximal anastomosis of the saphenous vein to the aorta. J Thorac Cardiovasc Surg. 2001; 121: 854858.
This article has been cited by other articles:
![]() |
J. D. Puskas, M. E. Halkos, H. Balkhy, M. Caskey, M. Connolly, J. Crouch, A. Diegeler, J. Gummert, W. Harringer, V. Subramanian, et al. Evaluation of the PAS-Port Proximal Anastomosis System in coronary artery bypass surgery (the EPIC trial) J. Thorac. Cardiovasc. Surg., July 1, 2009; 138(1): 125 - 132. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Puehler, S. Fraund-Cremer, J. Cremer, and A. Boening Successful six-year follow-up of a sutureless device for proximal anastomoses in a severely calcified ascending aorta Interactive CardioVascular and Thoracic Surgery, August 1, 2008; 7(4): 670 - 672. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Kempfert, U. T. Opfermann, M. Richter, T. Bossert, F. W. Mohr, and J. F. Gummert Twelve-Month Patency With the PAS-Port Proximal Connector Device: A Single Center Prospective Randomized Trial Ann. Thorac. Surg., May 1, 2008; 85(5): 1579 - 1584. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. J.L. Suyker and C. Borst Coronary Connector Devices: Analysis of 1,469 Anastomoses in 1,216 Patients Ann. Thorac. Surg., May 1, 2008; 85(5): 1828 - 1836. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Bergmann, K. Meszaros, S. Huber, P. Oberwalder, H. Machler, G. Schaffler, R. Rienmueller, and B. Rigler Forty-one-month follow-up of the Symmetry aortic connector system for proximal venous anastomosis J. Thorac. Cardiovasc. Surg., July 1, 2007; 134(1): 23 - 28. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Biancari, J. Lahtinen, R. Ojala, L. Ahvenjarvi, A. Jartti, M. Mosorin, J. Heikkinen, P. Taskinen, and M. Lepojarvi Spyder Aortic Connector System in Off-Pump Coronary Artery Bypass Surgery Ann. Thorac. Surg., July 1, 2007; 84(1): 254 - 257. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. F. Gummert, S. Demertzis, K. Matschke, U. Kappert, M. Anssar, F. Siclari, V. Falk, E. L. Alderman, and W. Harringer Six-Month Angiographic Follow-Up of the PAS-Port II Clinical Trial Ann. Thorac. Surg., January 1, 2006; 81(1): 90 - 96. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Kitamura, H. Okabayashi, M. Hanyu, Y. Soga, T. Nomoto, H. Johno, J. Nakano, T. Matsuo, M. Kai, and E. Umehara Early and midterm patency of the proximal anastomoses of saphenous vein grafts made with a Symmetry Aortic Connector System J. Thorac. Cardiovasc. Surg., October 1, 2005; 130(4): 1028 - 1031. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Aoki, A. T.L. Ong, A. Hoye, L. A. van Herwerden, J. E. Sousa, A. Jatene, J. J.R.M. Bonnier, J. P.M.A. Schonberger, N. Buller, R. Bonser, et al. Five year clinical effect of coronary stenting and coronary artery bypass grafting in renal insufficient patients with multivessel coronary artery disease: insights from ARTS trial Eur. Heart J., August 1, 2005; 26(15): 1488 - 1493. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. A. Frazier, F. Qureshi, K. M. Read, R. C. Gilkeson, R. S. Poston, and C. S. White Coronary Artery Bypass Grafts: Assessment with Multidetector CT in the Early and Late Postoperative Settings RadioGraphics, July 1, 2005; 25(4): 881 - 896. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Boening, F. Schoeneich, A. Lichtenberg, E. Bagaev, J. T. Cremer, and U. Klima First clinical results with a 30{degrees} end-to-side coronary anastomosis coupler Eur. J. Cardiothorac. Surg., May 1, 2005; 27(5): 876 - 881. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Dietrich, S. Martens, M. Kohlert, C. Herzog, M. F. Khan, G. Wimmer-Greinecker, and A. Moritz Decreased intermediate term patency of automated proximal anastomoses evaluated by sequential ultrafast CT Eur. J. Cardiothorac. Surg., April 1, 2005; 27(4): 579 - 583. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Wiklund, L.F. Bonilla, and E. Berglin A new mechanical connector for distal coronary artery anastomoses in coronary artery bypass grafting: A randomized, controlled study J. Thorac. Cardiovasc. Surg., January 1, 2005; 129(1): 146 - 150. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Matschke, U. Kappert, and J. Schneider Graft Occlusion After Deployment of the Aortic Connector Symmetry System: Is Anticoagulation a Necessity? Ann. Thorac. Surg., November 1, 2004; 78(5): 1878 - 1878. [Full Text] [PDF] |
||||
![]() |
O. Reuthebuch, A. Kadner, and M. I. Turina Reply Ann. Thorac. Surg., November 1, 2004; 78(5): 1878 - 1879. [Full Text] [PDF] |
||||
![]() |
B. Medalion, D. Meirson, E. Hauptman, L. Sasson, and A. Schachner Initial experience with the Heartstring proximal anastomotic system J. Thorac. Cardiovasc. Surg., August 1, 2004; 128(2): 273 - 277. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Redaelli, F. Maisano, G. Ligorio, E. Cattaneo, F.M. Montevecchi, and O. Alfieri Flow dynamics of the St Jude Medical Symmetry aortic connector vein graft anastomosis do not contribute to the risk of acute thrombosis J. Thorac. Cardiovasc. Surg., July 1, 2004; 128(1): 117 - 123. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Farhat, L. Chalabreysse, C. Diab, S. Aubert, and O. Jegaden Histological aspects of the saphenous vein damage with the use of the symmetry(R) aortic connector system Interactive CardioVascular and Thoracic Surgery, June 1, 2004; 3(2): 373 - 375. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Martens, M. Dietrich, C. Herzog, M. Doss, G. Schneider, A. Moritz, and G. Wimmer-Greinecker Automatic connector devices for proximal anastomoses do not decrease embolic debris compared with conventional anastomoses in CABG Eur. J. Cardiothorac. Surg., June 1, 2004; 25(6): 993 - 1000. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Okada, T. Sueda, K. Orihashi, and K. Imai Early type A dissection with the aortic connector device Eur. J. Cardiothorac. Surg., May 1, 2004; 25(5): 902 - 904. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. J. Cavendish, W. F. Penny, M. M. Madani, S. Keramati, O. Ben-Yehuda, D. G. Blanchard, E. Mahmud, A. Perricone, and S. Tsimikas Severe ostial saphenous vein graft disease leading to acute coronary syndromes following proximal aorto-saphenous anastomoses with the symmetry bypass connector device: Is it a suture device or a "stent"? J. Am. Coll. Cardiol., January 7, 2004; 43(1): 133 - 139. [Abstract] [Full Text] [PDF] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2003 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |